Samsung Biologics is committed to revolutionizing the biomedicine landscape by enhancing the development and manufacturing of high-quality therapeutic solutions. Our dedication to innovation and excellence in process development allows us to consistently refine our technologies, ensuring adherence to the highest CGMP manufacturing standards. Our state-of-the-art Bio R&D Lab focuses on cutting-edge mRNA-LNP technologies, which facilitate agile and scalable mRNA manufacturing, guaranteeing reliable and timely delivery for all clients.
Customized mRNA and LNP Manufacturing Solutions
Samsung Biologics stands out with its specialized team of experts dedicated to mRNA development and manufacturing. We provide tailored, end-to-end support for the production of mRNA and lipid nanoparticles (LNP). Our services are designed to accommodate scale-up studies of any size, ensuring precision, reproducibility, and compliance throughout the entire biopharma development process.
Comprehensive mRNA Development and Testing
Our fully integrated mRNA GMP manufacturing services encompass process development, analytical testing, and product characterization. This comprehensive framework enables a smooth transition from early discovery phases to clinical and commercial production. By adopting a rigorous scientific approach, we ensure robust scalability and adherence to global quality standards.
Streamlined Tech Transfer and Adaptable Scale-Up
In a rapidly evolving mRNA therapeutics landscape, efficient technology transfer and flexible scale-up are crucial. Samsung Biologics is committed to facilitating seamless tech transfers and adapting our scale-up capabilities from laboratory settings to commercial production. This adaptability ensures that your projects progress smoothly across various non-GMP and CGMP facilities without interruption.
Robust mRNA Manufacturing Workflow
Our manufacturing workflow encompasses all stages, from pDNA linearization to fill-finish processes, ensuring the on-time and complete delivery of mRNA vaccines and therapeutics. The integration of drug product and drug substance manufacturing at Samsung Biologics enables highly efficient upstream and downstream operations, all conducted under stringent CGMP conditions.
In-House Bioanalytical and Quality Control Expertise
Samsung Biologics boasts a comprehensive suite of in-house bioanalytical services, focusing on mRNA in vitro transcription (IVT), LNP formulation, and fill-finish processes. Our rapid turnaround times and commitment to regulatory compliance are upheld through extensive testing capabilities, including analytical testing, in-process control testing, release testing, and biosafety verification.
Innovative mRNA Sequence Design and Support
Our expertise extends to proprietary mRNA sequence design and AI-driven optimization techniques aimed at enhancing protein expression and stability. We offer biopharma manufacturing capabilities that support collaborative research and the development of RNA therapeutics tailored to specific project requirements.
Unlocking Your mRNA Potential
Samsung Biologics invites you to explore the full potential of your mRNA projects. Our commitment to excellence and innovation ensures that we can meet and exceed your development and manufacturing needs.
In conclusion, Samsung Biologics is at the forefront of mRNA manufacturing and development services, combining cutting-edge technology with rigorous quality standards. Our dedication to customization and efficiency positions us as a leader in the biopharmaceutical industry, ready to support your unique therapeutic endeavors.
- Expert Team: Access a specialized group focused on mRNA and LNP production.
- Seamless Integration: Benefit from a fully integrated approach to manufacturing and testing.
- Regulatory Compliance: Ensure adherence to global quality standards throughout the process.
- Rapid Tech Transfer: Experience efficient scale-up from lab to commercial production.
- Custom Solutions: Tailor services to fit specific project needs.
Read more → samsungbiologics.com